Relationship between epicardial adipose tissue adipocyte size and MCP-1 expression.

[1]  E. Dickson,et al.  Proinflammatory Phenotype of Perivascular Adipocytes: Influence of High-Fat Feeding , 2009, Circulation research.

[2]  Yeun-Chung Chang,et al.  Relations of epicardial adipose tissue measured by multidetector computed tomography to components of the metabolic syndrome are region-specific and independent of anthropometric indexes and intraabdominal visceral fat. , 2009, The Journal of clinical endocrinology and metabolism.

[3]  Á. L. Fernández,et al.  Extension of coronary artery disease is associated with increased IL-6 and decreased adiponectin gene expression in epicardial adipose tissue. , 2008, Cytokine.

[4]  J. González-Juanatey,et al.  Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension , 2008, Journal of Human Hypertension.

[5]  E. Maratos-Flier,et al.  Dietary Fatty Acids Differentially Regulate Production of TNF‐α and IL‐10 by Murine 3T3‐L1 Adipocytes , 2008, Obesity.

[6]  D. Laaksonen,et al.  Dietary fatty acids and cardiovascular disease: an epidemiological approach. , 2008, Progress in lipid research.

[7]  C. Hsieh,et al.  Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease , 2008, International Journal of Obesity.

[8]  C. Maffeis,et al.  Fat cell size, insulin sensitivity, and inflammation in obese children. , 2007, The Journal of pediatrics.

[9]  J. Tune,et al.  Adipokines and Coronary Vasomotor Dysfunction , 2007, Experimental biology and medicine.

[10]  S W Rabkin,et al.  Epicardial fat: properties, function and relationship to obesity , 2007, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[11]  C. Herder,et al.  Relationship between adipocyte size and adipokine expression and secretion. , 2007, The Journal of clinical endocrinology and metabolism.

[12]  S. Svacina,et al.  Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. , 2006, The Journal of clinical endocrinology and metabolism.

[13]  R. Kitazawa,et al.  MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.

[14]  S. B. Pedersen,et al.  Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. , 2005, The Journal of clinical endocrinology and metabolism.

[15]  F. Leonetti,et al.  Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. , 2005, Cytokine.

[16]  A. Madan,et al.  Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. , 2004, Endocrinology.

[17]  C. D. Krause,et al.  Interleukin-10 and related cytokines and receptors. , 2004, Annual review of immunology.

[18]  K. Wellen,et al.  Obesity-induced inflammatory changes in adipose tissue. , 2003, The Journal of clinical investigation.

[19]  B. Goldstein,et al.  Human Epicardial Adipose Tissue Is a Source of Inflammatory Mediators , 2003, Circulation.

[20]  P. Ferré,et al.  Adipocyte functions are modulated by cell size change: potential involvement of an integrin/ERK signalling pathway , 2003, International Journal of Obesity.

[21]  J. Janowska,et al.  Serum tumour necrosis factor-&agr;, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes , 2003, Coronary artery disease.

[22]  D. Loskutoff,et al.  Monocyte chemoattractant protein 1 in obesity and insulin resistance , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Yoon Lee,et al.  Tumor Necrosis Factor Receptor Superfamily 14 Is Involved in Atherogenesis by Inducing Proinflammatory Cytokines and Matrix Metalloproteinases , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[24]  C. Akdis,et al.  Mechanisms of interleukin‐10‐mediated immune suppression , 2001, Immunology.

[25]  L Wood,et al.  Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. , 2001, American journal of physiology. Endocrinology and metabolism.

[26]  Roy J Martin,et al.  Association of fat cell size and paracrine growth factors in development of hyperplastic obesity. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[27]  Z. Andrade,et al.  Interrelationship between adipocytes and fibroblasts during acute damage to the subcutaneous adipose tissue of rats: an ultrastructural study. , 1998, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[28]  R. Ross,et al.  Atherosclerosis is an Inflammatory Disease , 1998 .

[29]  P. Libby.  Atheroma: more than mush , 1996, The Lancet.

[30]  J. Hirsch,et al.  Adipose tissue cellularity in human obesity. , 1976, Clinics in endocrinology and metabolism.

[31]  R. Bonser,et al.  Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease , 2006, Cardiovascular diabetology.